Get the latest research on how Folia Health’s Home Reported Outcomes can surface unparalleled patient insights. No email required. Download buttons below!
Want to continue the conversation with the Folia Health team, and see how Folia’s mobile research platform can unlock a new layer in your evidence? Give us your details and we’ll be in touch!
Folia Health is pleased to submit a response to the FDA's Request for Information on Docket No. FDA-2026-N-4390, AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program.
We believe the success of this pilot program relies on the richness of the underlying data, which must represent the full impact of a drug candidate on the health status and disease burden of the patient. This is best accomplished by including real-time patient experience data in these programs, grounded in the methodology established by the FDA's PFDD guidance. Our decade of work with biopharma sponsors generating real-time patient-generated evidence reinforces this position.